2025 Annual Meeting | S1 - Innovations in Non-AD Dementia
Program Materials Program Evaluations
| 01:00 PM - 01:12 PM PDT | Speaker |
2025 Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases: This award recognizes major contributions to the understanding of the causes, prevention, treatment, and cure for Pick's, Alzheimer's, and related diseases
Gil D. Rabinovici, MD, FAAN |
| 01:12 PM - 01:24 PM PDT | Speaker |
2025 Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases: This award recognizes major contributions to the understanding of the causes, prevention, treatment, and cure for Pick's, Alzheimer's, and related diseases
William W. Seeley, MD |
| 01:24 PM - 01:36 PM PDT | Abstract |
003 - Accelerometer-Measured Physical Activity, Sedentary Behavior, and Incident Neuropsychiatric Diseases: A Large Prospective Cohort Study of 73,411 Participants
Jia-yi Wu, MD |
| 01:36 PM - 01:48 PM PDT | Abstract |
004 - Improving Early Recognition of Patients with Rapidly Progressive Dementia
Yoav Piura, MD |
| 01:48 PM - 02:00 PM PDT | Abstract |
005 - Normal Pressure Hydrocephalus: A Syndrome, Not a Disease.
Neill R. Graff-Radford, MD, FAAN |
| 02:00 PM - 02:12 PM PDT | Abstract |
006 - Anatomic Specificity of Inflammation TSPO PET Biomarkers in Dementia
Joseph C. Masdeu, MD, PhD, FAAN |
| 02:12 PM - 02:24 PM PDT | Abstract |
007 - A Longitudinal Quantitative Assessment of Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies
Christopher H. Gibbons, MD, FAAN |
| 02:24 PM - 02:36 PM PDT | Abstract |
008 - The Syn-D Study: Detection of Cutaneous Phosphorylated Alpha-Synuclein and blood P-Tau 217 in Patients with Mild Cognitive Impairment
Christopher H. Gibbons, MD, FAAN |
| 02:36 PM - 02:48 PM PDT | Abstract |
009 - APOE e4 Linked Effects on Neuropathology and Clinical Features in Dementia with Lewy Bodies
Rong Ye, MD, PhD |
| 02:48 PM - 03:00 PM PDT | Abstract |
010 - Association of Seizure Control and Neuropathology in Dementia
Rithvik Gundlapalli |
| Kathy L. Niu, MD | Dr. Niu has nothing to disclose. |
| Gil D. Rabinovici, MD, FAAN | Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA. |
| William W. Seeley, MD | Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative. |
| Christopher H. Gibbons, MD, FAAN | Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received publishing royalties from a publication relating to health care. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice. |
| Todd D. Levine, MD | Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has stock in CND Life Sciences. Dr. Levine has stock in Corinthian reference lab. |
| Bailey Bellaire | Bailey Bellaire has received personal compensation for serving as an employee of CND Life Sciences. |
| Roy L. Freeman, MD | Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. |
| Yoav Piura, MD | Dr. Piura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Piura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. |
| Gregory S. Day, MD, MSc, FAAN | Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parabon Nanolabs. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities. |
| Philip W. Tipton, MD | Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc. |
| Steven R. Dunham, Jr., MD | Dr. Dunham has nothing to disclose. |
| Nihal Satyadev, MD, MPH | Dr. Satyadev has nothing to disclose. |
| Neill R. Graff-Radford, MD, FAAN | The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care. |
| Rithvik Gundlapalli | Mr. Gundlapalli has received research support from University of Virginia School of Medicine. |
| Ifrah Zawar, MD | The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . |
| Jaideep Kapur, MD, PhD | The institution of Dr. Kapur has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Kapur has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Robert Wood Johnson Foundation . Dr. Kapur has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Kapur has received research support from NIH. Dr. Kapur has received intellectual property interests from a discovery or technology relating to health care. Dr. Kapur has a non-compensated relationship as a Chair, Board North America with International League against Epilepsy that is relevant to AAN interests or activities. Dr. Kapur has a non-compensated relationship as a Board of Directors with American Epilepsy Society that is relevant to AAN interests or activities. |
| Carol A. Manning, PhD | The institution of Dr. Manning has received research support from Department of Defense. |
| Prachi T. Parikh, MD | Dr. Parikh has nothing to disclose. |
| Mark S. Quigg, MD | Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care. |
| Jia-yi Wu, MD | Miss Wu has nothing to disclose. |
| Jintai Yu | No disclosure on file |
| Christian Lachner | Christian Lachner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView. |
| Olga Fermo, MD | Dr. Fermo has nothing to disclose. |
| Kaisorn Chaichana, MD | Dr. Chaichana has nothing to disclose. |
| Sanjeet S. Grewal, MD | Sanjeet S. Grewal, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. |
| Lauren Haydu, PhD | Ms. Haydu has nothing to disclose. |
| Joseph C. Masdeu, MD, PhD, FAAN | Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE. |
| Quentin Finn, PhD | Dr. Finn has nothing to disclose. |
| Alirexa Faridar, MD | Dr. Faridar has nothing to disclose. |
| Juan B. Toledo Atucha, MD, PhD | Dr. Toledo Atucha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Toledo Atucha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Toledo Atucha has received personal compensation in the range of $0-$499 for serving as a Consultant for SpearBio. Dr. Toledo Atucha has received personal compensation in the range of $0-$499 for serving as a Consultant for Newell. Dr. Toledo Atucha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Toledo Atucha has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EISAI. |
| Mohammad O. Nakawah, MD, FAAN | Dr. Nakawah has nothing to disclose. |
| Gustavo C. Roman, MD, FAAN | The institution of Dr. Roman has received research support from Brain Chamistry Labs. |
| Belen Pascual, PhD | The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH. |
| Stephen N. Gomperts, MD, PhD, FAAN | Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cowen. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bob's Last Stand. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus Boston. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expert connect. Dr. Gomperts has received personal compensation in the range of $0-$499 for serving as a Consultant for Mosaic. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from LBDA. The institution of Dr. Gomperts has received research support from DOD/CDMRP. The institution of Dr. Gomperts has received research support from FFFPRI. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. Dr. Gomperts has received intellectual property interests from a discovery or technology relating to health care. |
| Anna Goodheart, MD | The institution of Dr. Goodheart has received research support from 好色先生. |
| Erin Peterec, BA | Ms. Peterec has nothing to disclose. |
| Rong Ye, MD, PhD | Dr. Ye has nothing to disclose. |
| Marissa C. Natelson Love, MD, FAAN | Dr. Natelson Love has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium Pharma. Dr. Natelson Love has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Burns, Cunningham & Mackey. The institution of Dr. Natelson Love has received research support from Eisai. The institution of Dr. Natelson Love has received research support from Eli Lilly. The institution of Dr. Natelson Love has received research support from Janssen. The institution of Dr. Natelson Love has received research support from Vaccinex. |
| Jin-Tai Yu, PhD | Prof. Yu has nothing to disclose. |